Aemetis (NASDAQ:AMTX – Get Rating) posted its quarterly earnings data on Thursday. The specialty chemicals company reported ($0.03) earnings per share for the quarter, topping the consensus estimate of ($0.44) by $0.41, Fidelity Earnings reports. During the same quarter last year, the firm earned ($0.38) EPS.
Aemetis Trading Up 24.8 %
Shares of AMTX traded up $2.02 during trading hours on Friday, reaching $10.18. 2,464,266 shares of the stock traded hands, compared to its average volume of 658,733. The stock has a fifty day simple moving average of $6.33 and a 200 day simple moving average of $9.05. Aemetis has a 52 week low of $4.45 and a 52 week high of $23.33. The company has a market cap of $352.02 million, a price-to-earnings ratio of -9.01 and a beta of 0.62.
Analyst Ratings Changes
AMTX has been the subject of several recent analyst reports. Credit Suisse Group decreased their price objective on shares of Aemetis from $35.00 to $27.00 and set an “outperform” rating for the company in a research report on Monday, June 13th. Ascendiant Capital Markets cut shares of Aemetis to an “outperform” rating and set a $33.00 price objective for the company. in a research report on Monday, June 6th. One investment analyst has rated the stock with a sell rating and four have given a buy rating to the company’s stock. According to MarketBeat.com, Aemetis has an average rating of “Moderate Buy” and an average target price of $31.00.
Institutional Inflows and Outflows
Aemetis, Inc operates as a renewable natural gas and renewable fuels company in North America and India. It operates through three segments: California Ethanol, Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the acquisition, development, and commercialization of negative carbon intensity products and technologies that replace traditional petroleum-based products.
- Get a free copy of the StockNews.com research report on Aemetis (AMTX)
- MarketBeat: Week in Review 8/1 – 8/5
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Cronos Group Inc’s Revenues Are Up, Is It Time to Buy?
- Beyond Meat Is Not Beyond Hope, And It’s Cheap
- Why Apple Could Be At All-Time Highs By Year End
Receive News & Ratings for Aemetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aemetis and related companies with MarketBeat.com's FREE daily email newsletter.